The Saudi Music Commission Presents “Marvels of Saudi Orchestra”: A Unique Blend of Tradition and Innovation in Riyadh
RIYADH, Saudi Arabia, Jan. 9, 2025 /PRNewswire/ -- The Saudi Music Commission,…
Julien’s Auctions Presents Exclusive Bob Dylan Auction Featuring Al Aronowitz Archive and T Bone Burnett’s Ionic Original Recording
LOS ANGELES, Dec. 17, 2024 /PRNewswire/ -- Julien's Auctions will present "Celebrating…
Julien’s Auctions Presents Exclusive Bob Dylan Auction Featuring Al Aronowitz Archive and T Bone Burnett’s Ionic Original Recording
LOS ANGELES, Dec. 17, 2024 /PRNewswire/ -- Julien's Auctions will present "Celebrating…
Julien’s Auctions Presents Exclusive Bob Dylan Auction Featuring Al Aronowitz Archive and T Bone Burnett’s Ionic Original Recording
LOS ANGELES, Dec. 17, 2024 /PRNewswire/ -- Julien's Auctions will present "Celebrating…
Julien’s Auctions Presents Exclusive Bob Dylan Auction Featuring Al Aronowitz Archive and T Bone Burnett’s Ionic Original Recording
LOS ANGELES, Dec. 17, 2024 /PRNewswire/ -- Julien's Auctions will present "Celebrating…
Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium
December 11, 2024 07:05 ET | Source: Celcuity Inc. Median overall survival…
Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting
December 09, 2024 12:00 ET | Source: Disc Medicine Inc Positive updates…
CRISPR Therapeutics Presents Data atthe 2024 American Society of Hematology (ASH) Annual Meeting
December 09, 2024 12:00 ET | Source: CRISPR Therapeutics AG -Preliminary data…
Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivatat ASH 2024 and Provides Regulatory Update on Mitapivat
– ENERGIZE-T Study Achieved Primary and All Key Secondary Endpoints in Adult…
C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader
December 08, 2024 12:30 ET | Source: C4 Therapeutics, Inc. In Multiple…